-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
LEXICON PHARMACEUTICALS, INC. quarterly/annual Earnings Per Share, Diluted history and change rate from Q1 2015 to Q3 2025.
- LEXICON PHARMACEUTICALS, INC. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was -0.04 USD/shares, a 77.8% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. Earnings Per Share, Diluted for the twelve months ending 30 Sep 2025 was 0 USD/shares, a 76% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2024 was -0.63 USD/shares, a 21.3% increase from 2023.
- LEXICON PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2023 was -0.8 USD/shares, a 29% decline from 2022.
- LEXICON PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2022 was -0.62 USD/shares, a 3.33% decline from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)